Novel chimeric antigen receptors. Creating new molecules for next-generation anti-cancer therapy.
Natural killer cells. Creating enhanced cells with anti-tumour properties.
Precise genome engineering. Harvesting advances in genome engineering to the service of cell-therapeutics.
Stem cell derived therapeutics. Guided differentiation of cells towards therapeutic cells for cell replacement therapy and immunotherapy.
AI driven biosciences. High-throughput, high-content and automated labs for accelerated discovery of new therapeutics.